- Report
- April 2023
- 74 Pages
Europe
From €4100EUR$4,750USD£3,552GBP
- Report
- July 2024
- 302 Pages
Global
From €3108EUR$3,600USD£2,692GBP
- Report
- July 2024
- 136 Pages
Europe
From €1295EUR$1,500USD£1,122GBP
- Report
- July 2024
- 136 Pages
Asia Pacific
From €1295EUR$1,500USD£1,122GBP
- Report
- July 2024
- 120 Pages
North America
From €1295EUR$1,500USD£1,122GBP
- Report
- July 2024
- 136 Pages
Middle East, Africa
From €1295EUR$1,500USD£1,122GBP
- Report
- August 2022
- 108 Pages
Saudi Arabia
From €2892EUR$3,350USD£2,505GBP
- Report
- July 2023
- 82 Pages
Global
From €3500EUR$4,343USD£3,138GBP
The Feline Vaccine market is a segment of the Animal Pharmaceuticals industry that focuses on the development and distribution of vaccines for cats. Vaccines are used to protect cats from a variety of diseases, including feline leukemia, rabies, and feline infectious peritonitis. Vaccines are typically administered by veterinarians, and may be given as a single dose or as a series of doses. Vaccines are also available in a variety of forms, including injectable, oral, and intranasal.
The Feline Vaccine market is highly competitive, with a number of companies offering a wide range of products. Companies in the market include Merck Animal Health, Boehringer Ingelheim, Elanco, Zoetis, and Ceva Animal Health. These companies offer a variety of vaccines, including those for feline leukemia, rabies, and feline infectious peritonitis. Show Less Read more